Navigation Links
Trubion Pharmaceuticals Inc. Reports Second-Quarter and First-Half 2010 Financial Results
Date:8/16/2010

SEATTLE, Aug. 16 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals Inc. (Nasdaq: TRBN) today announced financial results for its second quarter and six months ended June 30, 2010.

(Logo: http://photos.prnewswire.com/prnh/20090320/TRUBIONLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20090320/TRUBIONLOGO)

Second-Quarter and First-Half 2010 Financial ResultsRevenue for the second quarter and six months ended June 30, 2010, increased to $5.7 million and $11.2 million, respectively, compared with $4.1 million and $8.3 million, respectively, in 2009. Revenue was primarily earned through the company's strategic collaborations with Pfizer, for the development of CD20-directed candidates, including SBI-087, and Abbott, for the development of CD37-directed targets, including TRU-016.

During the second quarter and first half of 2010, Trubion recognized $3.8 million in revenue from its Abbott collaboration. The $3.8 million includes recognition of $1.1 million from the $20 million upfront fee and $1.4 million equity premium received from Abbott, as well as $2.7 million earned through collaborative research.

The increase in revenue from the Abbott partnership was partially offset by lower revenue generated by Trubion's collaboration with Pfizer. The decrease in revenue was attributed to lower costs related to the retreatment studies of TRU-015 for rheumatoid arthritis (RA) as well as a decrease in the amount of reimbursable legal fees. Revenue earned from Trubion's partnership with Pfizer during the first half of the year was $7.4 million, which included $2.4 million for recognition of the $40 million upfront fee received in January 2006 and $5.0 million earned through collaborative research. This is compared with $8.
'/>"/>

SOURCE Trubion Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Trubion Pharmaceuticals Announces Presentation of Positive Data From Phase IIb and Re-treatment Studies With TRU-015 in Patients With Rheumatoid Arthritis
3. Trubion Announces Initiation of Phase I/II Clinical Trial of TRU-015 for the Treatment of B-Cell Non-Hodgkins Lymphoma
4. Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update
5. Trubion Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Rheumatoid Arthritis
6. Trubion Announces Initiation of Phase 2b Study of TRU-015 for the Treatment of Rheumatoid Arthritis
7. Trubion Announces Presentation of Positive TRU-016 Data at ASCO
8. Trubion Pharmaceuticals Announces Presentation of Positive TRU-015 and SBI-087 Data at the 2008 Annual European Congress of Rheumatology Meeting
9. Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
10. Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting
11. Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... DIEGO , Sept. 30, 2014 ... three-dimensional biology company focused on delivering breakthrough 3D ... Liver Model has been selected as a finalist in ... 2014 Most Innovative New Product Awards, sponsored by ... of innovative technology and life sciences products in ...
(Date:9/30/2014)... -- The Corporate Whistleblower Center is urging ER doctors, ... if they have well documented proof of a ... sent home, as an intentional way to overbill ... the Center would like to explain. http://CorporateWhistleblowerCenter.Com ... Photo - http://photos.prnewswire.com/prnh/20140929/149017 ...
(Date:9/30/2014)... EXECUTIVE SUMMARY The present report ... - Increasing Demand from Ageing Population to Drive ... past, present and future outlook. The report discusses ... market with outlook to 2017. Statistics include functional ... sub-segments of the industry, ongoing trends and developments, ...
Breaking Medicine Technology:Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 2Organovo Inc. Selected As A Finalist In 27th Annual CONNECT Most Innovative New Product Awards 3Corporate Whistleblower Center Urges ER Doctors or Nurse Managers to Call Them if They Have Proof of a Hospital Needlessly Admitting Medicare Patients Instead of Sending Them Home 2Corporate Whistleblower Center Urges ER Doctors or Nurse Managers to Call Them if They Have Proof of a Hospital Needlessly Admitting Medicare Patients Instead of Sending Them Home 3Corporate Whistleblower Center Urges ER Doctors or Nurse Managers to Call Them if They Have Proof of a Hospital Needlessly Admitting Medicare Patients Instead of Sending Them Home 4North America Nutraceuticals Industry Outlook to 2017- Increasing Demand from Ageing Population to Drive Growth 2North America Nutraceuticals Industry Outlook to 2017- Increasing Demand from Ageing Population to Drive Growth 3
(Date:9/30/2014)... Fla. (PRWEB) September 30, 2014 Lea ... is giving breast cancer patients a new, more practical ... , Women who undergo mastectomies, biopsies and lumpectomy surgeries ... promote healing. But after seeing her patients describe the ... compelled to create a new bra in her spare ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 AxoGen, ... focused on the peripheral nerve repair market, announced the ... during the American Society for Surgery of the Hand ... in Boston. , The ASSH Best ... Utilization of Processed Nerve Allografts for Large Gap Nerve ...
(Date:9/30/2014)... Brig Hart, one of the most ... 500 Diamond-ranked professionals using his systematic way of building ... The Life Support System for Ultimate Success , founded ... using his experiences and successes over the past 30 ... and methodology taught by Brig in this system, Mick ...
(Date:9/30/2014)... 30, 2014 During this online ... approaches to health including achieving hormonal balance, relieving ... and detoxification. , The details ... Date: October 6-9, 2014, Location: Online Event, Registration: ... http://www2.hotzehwc.com/naturalhealthsummitregistration , Monday, October 6th, Steven F. ...
(Date:9/30/2014)... 2014 Timber Home Living Magazine is documenting ... Olsen family’s reclaimed Douglas fir timber frame home in Austerlitz, ... from architectural planning, to the frame raising, to enclosure, to ... Energy Works, after following the timber framing company for years ... dream vacation home on land they fell in love with ...
Breaking Medicine News(10 mins):Health News:Surgeon Creates New Bra for Breast Cancer Patients, Post-Surgery 2Health News:Surgeon Creates New Bra for Breast Cancer Patients, Post-Surgery 3Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 2Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 3Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 4Health News:AxoGen, Inc. Announces Presentation of Clinical Data for Avance® Nerve Graft at American Society for Surgery of the Hand 2014 Annual Meeting 5Health News:Brig Hart Announces the First Diamond Elite Representatives using his Life Support System 2Health News:Brig Hart Announces the First Diamond Elite Representatives using his Life Support System 3Health News:Hotze Health & Wellness Center Announces First Natural Health Summit 2Health News:Reclaimed Timber Frame Home By New Energy Works Featured in Timber Home Living Magazine 2Health News:Reclaimed Timber Frame Home By New Energy Works Featured in Timber Home Living Magazine 3
... one of the most lethal cancers, with fewer than five ... new study that peers deeply into the genetics of pancreatic ... early diagnosis. In contrast to earlier predictions, many pancreatic tumors ... become lethal after the first genetic perturbations appear. "There ...
... People who regularly eat whole grains rather than refined grains ... a higher risk for heart disease and type 2 diabetes, ... (VAT) -- the fat that surrounds the intra-abdominal organs -- ... cholesterol and insulin resistance, health risk factors collectively known as ...
... , TUESDAY, Oct. 26 (HealthDay News) -- As many ... if people followed five simple healthy lifestyle recommendations, Danish ... overall health as well -- include exercise, a good ... weight, the researchers say. "Even a modest difference ...
... University and University of North Carolina (UNC) researchers report ... Research that narcotics and diagnostic testing are overused ... may overlook more effective treatments for neck pain, such ... study, evidence to support the effectiveness of therapeutic exercise ...
... Steven Reinberg HealthDay Reporter , TUESDAY, Oct. 26 ... the blood-thinning drug Plavix (clopidogrel) may be at increased risk ... finds. Having the gene variants seems to reduce the ... developing blood clots in the stent, suffering a heart attack ...
... -- Children who survive cancer face an increased risk ... The findings highlight the increased need for long-term ... researchers said. "Current treatments have dramatically increased survival ... many cancer therapies -- including surgery, radiation, and chemotherapy ...
Cached Medicine News:Health News:Revising the timeline for deadly pancreatic cancer 2Health News:Revising the timeline for deadly pancreatic cancer 3Health News:Eating Whole Grains, Fewer Refined Grains, May Help Heart 2Health News: Healthy Living Can Prevent Nearly 25% of Colorectal Cancers 2Health News: Healthy Living Can Prevent Nearly 25% of Colorectal Cancers 3Health News:Narcotics and diagnostics overused in treatment of chronic neck pain 2Health News:Gene Mutations May Blunt Plavix's Effectiveness, Study Finds 2Health News:Gene Mutations May Blunt Plavix's Effectiveness, Study Finds 3Health News:Childhood Cancer Survivors Risk Future GI Problems 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: